About
BRAXX Biotech focused on improving cancer radiotherapy. Based on clinical results, BRAXX developed the "BRAXX" esophagus applicator successfully, which is the only applicator that can be trans-nasal placed among the market and already reimbursed by NHI system in Taiwan.
Technologies
Outlook
Microsoft Office 365
Amazon AWS
Ubuntu
Apache
reCAPTCHA
WordPress.org
Mobile Friendly
Google Tag Manager
Keywords
radiation oncology
medical device
esophageal cancer
medical equipment manufacturing
feasibility studies
clinical needs
fda clearance
international patent strategy
medical devices
precise positioning
regulation and compliance
asia healthcare burden
healthcare equipment & supplies
new cancer treatment tools
services
patient treatment options
cancer treatment
unmet clinical needs
therapy optimization
innovative medical products
tfda approved
esophageal applicator
medical device regulation
side effect reduction
medical device research
esophageal brachytherapy
radiation therapy
tfda approval
medical device r&d
brachytherapy applicator
Company Information
-
Employees 3
-
Founded 2016
Location
Taipei, Taiwan
